TrialJournal of the American Society of Nephrology : JASN2016

Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial.

Nisha Bansal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.